CTRI/2021/10/037378已完成2 期
A Study To Assess Efficacy And Safety Of Polyherbal Formulation (COVI-RB01) As An Add-On Therapy With Standard of Care In Mild And Moderate Covid-19 Positive Patients - COVI-RB01
Alakart Bio Pharma Pvt Ltd0 个研究点目标入组 130 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 130
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •RT-PCR based diagnosis of COVID-19
- •- Treatment trials: cases of mild and moderate severity.
- •- Willingness to participate.
排除标准
- •- Severe category (Spo2 < 90).
- •- Individuals with uncontrolled, unstable co-morbidities.
- •- Individuals with pre-existing respiratory conditions. Immuno-compromised individuals or those on immuno-suppressants.
- •- Pregnant and lactating females.
研究者
相似试验
招募中
2 期
Clinical Study to Evaluate the Effect of Polyherbal Unani formulations in Waram-e-lawzatayn Muzmin (Chronic Tonsillitis).CTRI/2023/09/057524Ministry of Ayush UP
招募中
2 期
Clinical Study To Evaluate the efficacy of polyherbal Unani formulation in Zukam (Coryza OR Common Cold)CTRI/2023/08/056975State Unani Medical College
招募中
3 期
CLINICAL RESEARCH ON SIDDHA MEDICINE IN IYA ERAIPPU NOI(BRONCHIAL ASTHMA)CTRI/2013/12/004253AYOTHIDOSS PANDITHAR HOSPITA125
尚未招募
2 期
To Asses efficacy and safety of polyherbal unani formulation In NazlaCTRI/2023/10/058727State Unani Medical College Himmatganj Prayagraj
尚未招募
2 期
Evaluation of efficacy and safety of Polyherbal Unani formulations in the management of EczemaCTRI/2024/02/062979Hakim Syed Ziaul Hasan Government Unani Medical College and Hospital Ayush